SEC 13F Intelligence

CHECKPOINT THERAPEUTICS INC

CUSIP 162828206

Checkpoint Therapeutics Inc has 30 institutional holders in Filings Flow’s 13F database, together reporting 1.23M shares worth $19M as of Q4 2022.

Institutional Holders
30
Q4 2022
Reported Value
$19M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2

Ownership Trend

Institutional holders
Q4 ’22: 30Q4 ’22Q2 ’26: 1Q2 ’26filingsflow.com
Total reported value
Q4 ’22: $19MQ4 ’22Q2 ’26: $9MQ2 ’26filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
ROYAL BANK OF CANADA$570.1B AUM0.00%$243,00060.2KQ3 2025OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.